Clinical Trials Browser

Phase 2 × OTHER_GOV × Hodgkin Disease × Clear all

NCT01079013 2016-04-20

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02507479 2016-04-20

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Phase 2 Unknown

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00163748 2016-01-08

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT01164345 2015-12-03

Mozobil for Autologous Stem Cell Mobilization

Phase 2 Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT01300156 2011-02-21

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Recurrence